The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 15, 2015

Filed:

Jan. 10, 2013
Applicant:

Board of Regents, the University of Texas System, Austin, TX (US);

Inventors:

Steven J. Norris, Houston, TX (US);

Jing-Ren Zhang, Beijing, CN;

John M. Hardham, Kalamazoo, MI (US);

Jerrilyn K. Howell, Houston, TX (US);

Alan G. Barbour, Newport Beach, CA (US);

George M. Weinstock, St. Louis, MO (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/40 (2006.01); A61K 39/02 (2006.01); C07K 16/12 (2006.01); A61K 39/44 (2006.01); C07K 14/20 (2006.01); G01N 33/569 (2006.01); G11B 7/007 (2006.01); G11B 7/128 (2012.01); G11B 7/0065 (2006.01);
U.S. Cl.
CPC ...
C07K 16/1207 (2013.01); A61K 39/44 (2013.01); C07K 14/20 (2013.01); G01N 33/56911 (2013.01); G11B 7/00772 (2013.01); G11B 7/128 (2013.01); A61K 39/00 (2013.01); A61K 39/02 (2013.01); A61K 39/40 (2013.01); C07K 2319/00 (2013.01); G01N 2333/20 (2013.01); G11B 7/0065 (2013.01);
Abstract

The present invention relates to DNA sequences encoding Vmp-like polypeptides of pathogenic Borreliae, the use of the DNA sequences in recombinant vectors to express polypeptides, the encoded amino acid sequences, application of the DNA and amino acid sequences to the production of polypeptides as antigens for immunoprophylaxis, immunotherapy, and immunodiagnosis. Also disclosed are the use of the nucleic acid sequences as probes or primers for the detection of organisms causing Lyme disease, relapsing fever, or related disorders, and kits designed to facilitate methods of using the described polypeptides, DNA segments and antibodies.


Find Patent Forward Citations

Loading…